LIR Life Sciences Corp.
BBCMF
$0.20
$0.000.00%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.75% | -11.07% | 40,073.68% | -97.83% | -- |
| Total Receivables | 35.08% | 136.60% | 73.86% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 142.53% | 605.41% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.28% | -2.38% | 7,244.86% | -87.77% | -- |
|
|
|||||
| Total Current Assets | -20.28% | -2.38% | 7,244.86% | -87.77% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 2.05% | -2.53% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -27.35% | -2.01% | 900.23% | -1.83% | -- |
|
|
|||||
| Total Accounts Payable | 41.67% | -84.32% | 35.44% | 84.62% | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 128.99% | -84.32% | 23.88% | 101.84% | -- |
|
|
|||||
| Total Current Liabilities | 128.99% | -84.32% | 23.88% | 101.84% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 128.99% | -84.32% | 23.88% | 101.84% | -- |
|
|
|||||
| Common Stock & APIC | 22.72% | 130.02% | 386.34% | -0.14% | -- |
| Retained Earnings | -46.11% | -287.24% | -31.47% | -30.82% | -- |
| Treasury Stock & Other | 27.61% | -- | -- | -- | -- |
| Total Common Equity | -38.84% | 59.46% | 333.46% | -254.71% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.84% | 59.46% | 333.46% | -254.71% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.84% | 59.46% | 333.46% | -254.71% | -- |
|
|
|||||